STONKWHISPER
← Back to Intel
Insider ActivitySMMT

Zanganeh Mahkam, Co-Chief Executive Officer, Director, 10% Owner at Summit Therapeutics Inc., bought $1.5M of SMMT

Updated Jun 19, 2026
Zanganeh Mahkam Co-Chief Executive Officer, Director, 10% Owner
Summit Therapeutics Inc. · $SMMT
$1.5M Total Value
100,000 Shares Traded
$14.6 Price / Share
25,824,474 Shares Owned After
2026-06-04 Filing Date

Transaction Details

InsiderZanganeh Mahkam
TitleCo-Chief Executive Officer, Director, 10% Owner
CompanySummit Therapeutics Inc.
TickerSMMT
Transaction TypePurchase
Transaction Date2026-06-04
Shares Traded100,000
Price Per Share$14.6
Total Value$1.5M
Filed Date2026-06-04
Accession Number0001507650-26-000005

Ownership Context

Shares Owned After Transaction25,824,474
Ownership TypeIndirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001507650-26-000005

Other Insider Trades — SMMT

Other Trades by Zanganeh Mahkam

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for SMMT — Summit Therapeutics Inc. →

Whisper Score — SMMT

50.0
Active Discussion
Current Whisper Score

See full analysis for SMMT →

Track SMMT insider activity in real time on The Wire →

Get alerts when Zanganeh Mahkam files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:03 UTC

Want real-time data? Access The Wire for live sentiment tracking.